Accedi

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.

α-Adrenoceptors

α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic effector cells, mainly in smooth muscles, have three subtypes: α1A, α1B, and α1D. The α2 adrenoceptors are found in presynaptic adrenergic neurons, lipocytes, platelets, and smooth muscles and have three subtypes: α2A, α2B, and α2C.

ꞵ-Adrenoceptors

ꞵ-adrenoceptors have three subtypes: ꞵ1, ꞵ2, and ꞵ3. The β1 adrenoceptors are located postsynaptically on effector organs such as the heart, brain, and lipocytes. While presynaptically, they are located in adrenergic and cholinergic nerve terminals, renal juxtaglomerular cells, and ciliary epithelial cells. The β2 adrenoceptors are found on postsynaptic effector cells, cardiac and smooth muscles. They are also present postsynaptically in lipocytes and cardiac tissues.

Adrenoceptors Are Membrane-bound G protein–coupled Receptors

α1 adrenoceptor stimulation activates phospholipase C, producing IP3 and DAG as second messengers. α2 adrenoceptor activation inhibits adenylyl cyclase (decreasing cAMP level) and modulates Ca2+ and K+ ion channels. All types of β-adrenoceptors activate adenylyl cyclase.

α1 adrenoceptor stimulation constricts blood vessels, increases salivation, relaxes the GI smooth muscles, and increases hepatic glycogenolysis. α2 adrenoceptor stimulation, on the other hand, inhibits transmission and release of the autonomic neurotransmitters noradrenaline and acetylcholine, platelet aggregation, vascular smooth muscle contraction, and insulin release inhibition. Stimulation of β1 adrenoceptor increases heart rate and contraction force. β2 adrenoceptor stimulation causes bronchodilatation, vasodilatation, visceral smooth muscle relaxation, hepatic glycogenolysis, and muscle tremors. β3 adrenoceptor stimulation is responsible for lipolysis, thermogenesis, and relaxation of the detrusor muscle in the bladder.

Tags

Adrenergic ReceptorsAdrenoceptorsNoradrenalineCatecholamines1 Adrenoceptors2 Adrenoceptors1 Adrenoceptors2 Adrenoceptors3 AdrenoceptorsG Protein coupled ReceptorsPhospholipase CCAMPBlood Vessel ConstrictionMuscle RelaxationLipolysisThermogenesis

Dal capitolo 6:

article

Now Playing

6.2 : Adrenergic Receptors (Adrenoceptors): Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.0K Visualizzazioni

article

6.1 : Neuroni adrenergici: neurotrasmissione

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.2K Visualizzazioni

article

6.3 : Recettori adrenergici: ɑ Sottotipo

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Visualizzazioni

article

6.4 : Recettori adrenergici: sottotipo β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Visualizzazioni

article

6.5 : Agonisti adrenergici: agenti ad azione diretta

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Visualizzazioni

article

6.6 : Agonisti adrenergici: agenti ad azione indiretta

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Visualizzazioni

article

6.7 : Agonisti adrenergici: agenti ad azione mista

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

605 Visualizzazioni

article

6.8 : Agonisti adrenergici: chimica e relazione struttura-attività

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.4K Visualizzazioni

article

6.9 : Agonisti adrenergici: classificazione terapeutica

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

606 Visualizzazioni

article

6.10 : Agonisti adrenergici: usi terapeutici

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

670 Visualizzazioni

article

6.11 : Antagonisti adrenergici: chimica e classificazione dei bloccanti del recettore ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

726 Visualizzazioni

article

6.12 : Antagonisti adrenergici: azioni farmacologiche dei bloccanti del recettore ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

497 Visualizzazioni

article

6.13 : Antagonisti adrenergici: chimica e classificazione dei bloccanti del β-recettore

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

433 Visualizzazioni

article

6.14 : Antagonisti adrenergici: azioni farmacologiche dei bloccanti del β-recettore

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

468 Visualizzazioni

article

6.15 : Antagonisti adrenergici: ɑ e bloccanti dei recettori β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

373 Visualizzazioni

See More

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati